Posts

Key TakeawaysUsing two different COVID-19 vaccines for first and second doses is more likely to lead to side effects, according to preliminary study results.The reactions after the second dose were the same as those commonly seen after getting the same vaccine for both shots—fever, chills, fatigue, and headache.The study only reported on the reaction profile for using different vaccines, not whether effectiveness changes. A report on the effectiveness of mixed doses of vaccine will be released in a few weeks....

Table of ContentsView AllTable of ContentsWhat Is Prednisone?What Is Tylenol?Safety Information Table of ContentsView All View All Table of Contents What Is Prednisone? What Is Tylenol? Safety Information Tylenol (acetaminophen) is a pain reliever commonly used to manage mild to moderate pain fromheadaches, muscle aches, menstrual periods, colds and sore throats, toothaches, backaches, and reactions to vaccinations. No interaction has been found between the two medications so far. However, you should always consult your healthcare provider before starting a new medication....

Key TakeawaysCalorie restriction has been shown to enhance lifespan in animal studies but there’s limited data on its risks and benefits for humans.A new report from Yale suggested that calorie reduction may benefit the thymus gland, an organ that creates a type of white blood cells to fight infections.The researchers also identified a protein that could be important for understanding the metabolic effects of caloric reduction. Key Takeaways Calorie restriction has been shown to enhance lifespan in animal studies but there’s limited data on its risks and benefits for humans....

If you sit for most of the day, even moderate exercise may not undo the health risks of prolonged sitting, according to a new study published in the journalPLoS ONE. The study included people ages 28 to 49 who, on average, spend more than 8.5 hours sitting each day. Even when participants met the recommended 150 minutes of moderate exercise or 75 minutes of vigorous exercise per week, they still had higher levels of body mass index (BMI) and elevated total cholesterol....

Key TakeawaysModerna and Pfizer have released some preliminary human data about the efficacy of their updated COVID-19 bivalent boosters.The Omicron-targeting bivalent boosters appear to elicit a strong immune response, but it’s not yet clear just how durable the protection will be.The companies say they will share more data from clinical trials in the coming months.Moderna and Pfizer have finally shared some clinical trial data about their updated bivalent booster shots. But it doesn’t tell us a whole lot....

Key TakeawaysCOVID-19 vaccines and boosters have been free because of federal funding. However, if that funding stops, people may have to pay out of pocket for the shots.Pfizer reportedly plans to price their COVID-19 vaccines at $110 to $130 per dose.Moderna released similar pricing, but has rolled it back in a commitment to keep their vaccines free. Key Takeaways COVID-19 vaccines and boosters have been free because of federal funding. However, if that funding stops, people may have to pay out of pocket for the shots....

Key Takeaways If you’ve received two doses of the Moderna vaccine, scientists are getting closer to pinpointing exactly how long you’ll be protected. New research suggests your vaccine-induced antibodies will protect you from COVID-19 for at least six months. Lead study author Nicole Doria-Rose, PhD, a scientist at the National Institutes of Health, tells Verywell antibodies—which are proteins in the blood that fight viruses—were found in healthy adults up to six months after their second Moderna dose....

Key TakeawaysModerna found that its vaccine may be less effective against the South African strain of SARS-CoV-2, the virus that causes COVID-19.The company is creating a booster shot to target the variant.Moderna is also studying a booster that could work with other vaccines, too. Key Takeaways Moderna found that its vaccine may be less effective against the South African strain of SARS-CoV-2, the virus that causes COVID-19.The company is creating a booster shot to target the variant....

Key TakeawaysTwo major pharmaceutical companies are working on combination COVID-19 booster and flu vaccines.Both Novavax and Moderna announced the news last week.Doctors say these types of shots make getting vaccinated more convenient. Key Takeaways Two major pharmaceutical companies are working on combination COVID-19 booster and flu vaccines.Both Novavax and Moderna announced the news last week.Doctors say these types of shots make getting vaccinated more convenient. Pharmaceutical company Moderna shared last week that it is working on a vaccine that will combine a COVID-19 booster dose with a seasonal flu shot....

Key TakeawaysModerna shared promising data from a phase 3 clinical trial of its RSV vaccine for adults ages 60 and older this week.The respiratory virus can cause particularly severe disease in babies and older adults.Several other companies are developing RSV vaccines, some of which are expected to be approved later this year. Key Takeaways Moderna shared promising data from a phase 3 clinical trial of its RSV vaccine for adults ages 60 and older this week....

Key TakeawaysModerna’s chief science officer announced that the company believes it’s mRNA vaccine will provide immunity for at least a year.The drugmaker says it is on track to deliver at least 600 million doses of the vaccine in 2021.Moderna says it is well suited to deal with new COVID-19 variants as they arise.Immunity from Moderna’s COVID-19 vaccine should last for at least a year, the company told investors at the J....

Key TakeawaysModerna’s mRNA technology was so effective in its COVID-19 shot that the company is using the same approach to develop vaccines against other viruses like flu and HIV.Unlike traditional vaccines, the mRNA technology can build proteins that teach the immune system to recognize a virus—it’s more effective against variants.If successful, the COVID-19 pandemic may have provided scientists with the tools to combat viruses that have been plaguing humans for decades....

Key TakeawaysModerna said it will ask the FDA to authorize its pediatric COVID-19 vaccine for use in children between the ages of 6 months and under 6 years old.The company said the vaccine produced a strong immune response despite being only about 40% effective at preventing symptomatic COVID-19.The vaccine was tested in this age group during the Omicron wave.Study participants only experienced mild and moderate side effects. Key Takeaways Moderna said it will ask the FDA to authorize its pediatric COVID-19 vaccine for use in children between the ages of 6 months and under 6 years old....